Abstract
Two studies have shown that oncolytic virus treatment prior to surgery can prime the tumour immune microenvironment for subsequent immune checkpoint inhibition and lead to better outcomes in preclinical models of breast and brain cancers.
Cite
CITATION STYLE
APA
Dart, A. (2018). Viral reprogramming. Nature Reviews Cancer, 18(3), 135–135. https://doi.org/10.1038/nrc.2018.12
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free